These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 8017497)

  • 1. Are you up to date on diabetes medications?
    Kestel F
    Am J Nurs; 1994 Jul; 94(7):48-52. PubMed ID: 8017497
    [No Abstract]   [Full Text] [Related]  

  • 2. [What is new in the treatment of diabetes mellitus?].
    Gain T
    Krankenpfl J; 2000 Oct; 38(9-10):328-31. PubMed ID: 11194350
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin delivery devices--pumps and pens.
    Hirsch IB
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S115-6. PubMed ID: 20515300
    [No Abstract]   [Full Text] [Related]  

  • 4. Rationale for using combinations of short-acting insulin analogue and NPH insulin at mealtime in the treatment of type 1 diabetes mellitus.
    Bolli GB
    J Pediatr Endocrinol Metab; 1999; 12 Suppl 3():737-44. PubMed ID: 10626264
    [No Abstract]   [Full Text] [Related]  

  • 5. [Documented advantages of insulin Lantus when compared with NPH insulin].
    Frid A
    Lakartidningen; 2004 Sep; 101(39):3014. PubMed ID: 15493644
    [No Abstract]   [Full Text] [Related]  

  • 6. Addition of insulin to oral therapy in type 2 diabetes.
    Dağdelen S
    N Engl J Med; 2008 Mar; 358(11):1197; author reply 1198. PubMed ID: 18337612
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy in NIDDM.
    Raskin P
    N Engl J Med; 1992 Nov; 327(20):1453-4. PubMed ID: 1406863
    [No Abstract]   [Full Text] [Related]  

  • 8. [Documented advantages of Lantus in comparison with NPH].
    Birgersson MO
    Lakartidningen; 2004 Oct; 101(42):3270, 3273; author reply 3273. PubMed ID: 15544137
    [No Abstract]   [Full Text] [Related]  

  • 9. The journey to metabolic control in diabetes: many more miles to go.
    Silverstein JH; Rosenbloom AL
    J Pediatr; 2003 Dec; 143(6):704-6. PubMed ID: 14657811
    [No Abstract]   [Full Text] [Related]  

  • 10. [Care of people with diabetes in the pharmacy].
    Müller U
    Pharm Unserer Zeit; 2012 Jul; 41(4):313-22. PubMed ID: 22764001
    [No Abstract]   [Full Text] [Related]  

  • 11. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial rather than preprandial glucose levels should be used for adjustment of rapid-acting insulins.
    Bell DS; Ovalle F; Shadmany S
    Endocr Pract; 2000; 6(6):477-8. PubMed ID: 11155223
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insulin therapy in 1970 and various reflections on the oral treatment of diabetes].
    Deuil R
    Acquis Med Recent; 1970; ():65-81. PubMed ID: 5526183
    [No Abstract]   [Full Text] [Related]  

  • 14. [New insulin with uniform action. Hazards of blood sugar variations minimized].
    MMW Fortschr Med; 2003 Oct; 145(40):55. PubMed ID: 14603609
    [No Abstract]   [Full Text] [Related]  

  • 15. [Practical points in the use of insulin and oral hypoglycemic agents].
    Nakayama H
    Hokkaido Igaku Zasshi; 1989 Jul; 64(4):387-90. PubMed ID: 2684832
    [No Abstract]   [Full Text] [Related]  

  • 16. [New methods in insulin treatment].
    Neuwirth G
    Orv Hetil; 2005 Jan; 146(3):111-6. PubMed ID: 15693442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and oral hypoglycemic agents.
    Price MJ
    Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
    [No Abstract]   [Full Text] [Related]  

  • 18. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C; Hernández Herrero C; Rivas Fernández M
    Diabet Med; 2008 Aug; 25(8):916-23. PubMed ID: 18959604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes: controlling the insulin balance. The pharmacologic repertoire.
    Flavin K; Haire-Joshu D
    Am J Nurs; 1986 Nov; 86(11):1244-51. PubMed ID: 3535510
    [No Abstract]   [Full Text] [Related]  

  • 20. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.
    Haak T; Tiengo A; Draeger E; Suntum M; Waldhäusl W
    Diabetes Obes Metab; 2005 Jan; 7(1):56-64. PubMed ID: 15642076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.